"Designing Growth Strategies is in our DNA"

Gallbladder Cancer Treatment Market Size, Share and Global Trend By Indication (Stage I, Stage II, Stage II, Stage IV), By Treatment (Radition Therapy, Chemotherapy, Immunotherapy, Others), By End User (Hospitals, Gynecology Clinics, Academic & Research Centers, Others) and Geography Forecast till 2022-2029

Region : Global | Report ID: FBI101001 | Status : Ongoing

 

KEY MARKET INSIGHTS

Gallbladder cancer occurs when healthy cells in the gallbladder start growing rapidly, forming a mass called a tumor. A cancerous tumor is malignant, which can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread. Gallbladder cancer is a rare disease in which malignant (cancer) cells are found in the tissues of the gallbladder. The symptoms include jaundice pain, above the stomach, fever, nausea, and vomiting, bloating and lumps in the abdomen. Gallbladder cancer can be diagnosed by blood tests, ultrasound, CT scan, MRI, cholangiogram, angiography, and others.


Sedentary lifestyle, obesity and increasing consumption of tobacco and smoking are some of the major factors contributing to the increasing prevalence of gallbladder cancer globally. This combined with the introduction of new drugs by market players for the treatment of gallbladder cancer, are factors projected to fuel the demand, and drive the growth of the global gallbladder cancer treatment market during 2019-2026.

To gain extensive insights into the market, Request for Customization


However, lack of a comprehensive treatment method for gallbladder cancer, along with the longer duration of the treatment are some of the major factors deterring patients to undergo treatment, and in turn, restraining the growth of the global gallbladder cancer treatment market.


Key Players Covered


Some of the major companies that are present in the global gallbladder cancer treatment market are Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi, and others. and others.


SEGMENTATION 


























SEGMENTATION



 DETAILS



By Indication



· Stage I


· Stage II


· Stage II


· Stage IV



By Treatment



· Radition Therapy


· Chemotherapy


· Immunotherapy


· Others



By End-User



· Hospitals


· Gynecology Clinics


· Academic & Research Centres


· Others



By Geography



· North America (USA and Canada)


· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


· Latin America (Brazil, Mexico and Rest of Latin America)


· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



In 2018, among treatment type, chemotherpy therapy dominated the global gallbladder cancer treatment market due to introduction of new chemotherpy drugs in the market. This segment is projected to grow at comparatively higher CAGR during the forecast period.


Key Insights



  • Epidemiology Gallbladder Cancer (Key Countries/Regions)

  • The Economic Cost Burden of Gallbladder Cancer Treatment

  • Pricing Analysis, By Treatment Type

  • Recent Industry Developments Such as Partnerships, Mergers, and Acquisitions


Regional Analysis


North America dominated the global gallbladder cancer treatment market in 2018. According to studies conduced by Centers for Disease Control and Prevention (CDC), about 3,700 people were suffering from gallbladder cancer. The increasing prevalence of gallbladder cancer is anticipated to increase the demand for the treatment susequnetly driving the growth of the global gallbladder cancer treatment market. This combined with a higher cost of the therapies in these countries and higher per capita healthcare expenditure are some of the factors responsible for a comparatively higher share of North America in the global gallbladder cancer treatment market in 2018. According to the American Cancer Society, an estimated 11,740 new cases of gallbladder cancer were diagnosed in 2017.


Key Industry Developments



  • In May 2017, EMD Serono, Inc., recived US Food and Drug Administration (FDA) approval for the the immunotherapy drug Bavencio (avelumab) to treat people with advanced urothelial carcinoma, the most common type of bladder cancer.
  • In May 2016, F. Hoffmann-La Roche Ltdn launched ew immunotherapy drug, atezolizumab, has been approved for patients with metastatic urothelial carcinoma, a type of bladder cancer.

  • Ongoing
  • 2021
  • 2018-2020

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850
    Pre Book

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

abbvie
Galemed
Jubilant
uniliver
Siemens Healthineers

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X